Published in FEBS Lett on October 15, 1990
Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A (1993) 2.67
Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J (1998) 1.83
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A (1995) 1.32
The extracellular regulation of growth factor action. Mol Biol Cell (1992) 1.25
Identification and molecular cloning of a soluble human granulocyte-macrophage colony-stimulating factor receptor. Proc Natl Acad Sci U S A (1991) 1.25
Purification and characterization of a novel soluble receptor for interleukin 1. J Exp Med (1991) 1.21
Molecular basis of the membrane-anchored and two soluble isoforms of the human interleukin 5 receptor alpha subunit. Proc Natl Acad Sci U S A (1992) 1.16
The inhibitory activity of human interleukin-1 receptor antagonist is enhanced by type II interleukin-1 soluble receptor and hindered by type I interleukin-1 soluble receptor. J Clin Invest (1995) 1.15
Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease. Clin Exp Immunol (2004) 1.14
Inhibition of interleukin-1 responsiveness by type II receptor gene transfer: a surface "receptor" with anti-interleukin-1 function. J Exp Med (1996) 1.06
High affinity type I interleukin 1 receptor antagonists discovered by screening recombinant peptide libraries. Proc Natl Acad Sci U S A (1996) 0.97
Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells. J Exp Med (1995) 0.94
Determination of soluble CD21 as a parameter of B cell activation. Clin Exp Immunol (1993) 0.89
Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma. PLoS One (2015) 0.77
Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A (1997) 6.99
Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet (1988) 3.50
Heat-shock protein 65 as a beta cell antigen of insulin-dependent diabetes. Lancet (1990) 3.46
Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet (1992) 3.12
The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol (1997) 2.87
Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet (1993) 2.57
Arterial inflammation in mice lacking the interleukin 1 receptor antagonist gene. J Exp Med (2000) 2.50
The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. J Immunol Methods (1982) 2.49
An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med (1993) 2.30
Interleukin 1: the first interleukin. Immunol Today (1990) 2.27
Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation (1999) 2.17
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology (1994) 2.05
A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum (1995) 1.85
Mechanisms of fever induced by recombinant human interferon. J Clin Invest (1984) 1.81
Urate crystals stimulate production of tumor necrosis factor alpha from human blood monocytes and synovial cells. Cytokine mRNA and protein kinetics, and cellular distribution. J Clin Invest (1991) 1.75
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol (1988) 1.70
Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J Immunol (2000) 1.68
Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet (1992) 1.63
A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics (1994) 1.57
Primary biliary cirrhosis shows association with genetic polymorphism of tumour necrosis factor alpha promoter region. J Hepatol (1999) 1.54
Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum (1994) 1.48
Patient stratification for preventive care in dentistry. J Dent Res (2013) 1.46
Evidence that brain prostaglandin synthesis is not essential in fever. J Physiol (1976) 1.45
Serum interleukin-2-receptor in rheumatoid arthritis: a prognostic indicator of disease activity? J Autoimmun (1988) 1.38
The detection of endotoxin by in vitro production of endogenous pyrogen: comparison with limulus amebocyte lysate gelation. J Immunol Methods (1982) 1.38
Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol (1994) 1.33
Soluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonist. Proc Natl Acad Sci U S A (1995) 1.32
Sequence homologies between hsp60 and autoantigens. Immunol Today (1993) 1.32
Soluble interleukin 2 receptor in atopic eczema. BMJ (1989) 1.28
Soluble CD4 in patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol (1991) 1.25
IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun (2001) 1.25
The pyrogenic and mitogenic actions of interleukin-1 are related. Nature (1983) 1.25
Purification and characterization of a novel soluble receptor for interleukin 1. J Exp Med (1991) 1.21
Thermoregulation in rabbits during fever. J Physiol (1976) 1.20
Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. Arthritis Rheum (1985) 1.20
An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis (2000) 1.18
Fever and immunoregulation: hyperthermia, interleukins 1 and 2, and T-cell proliferation. Yale J Biol Med (1983) 1.12
A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol (1994) 1.10
Soluble CD8 in patients with rheumatic diseases. Clin Exp Immunol (1990) 1.09
In situ hybridization of IL-6 in rheumatoid arthritis. Clin Exp Immunol (1992) 1.09
Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol (2000) 1.09
Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response. J Exp Med (1983) 1.08
Interleukin 1 receptor antagonist gene polymorphism association with lichen sclerosus. Hum Genet (1994) 1.08
Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol (2000) 1.07
Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. J Periodontol (2000) 1.07
Identification of an interleukin-1 beta binding protein in human plasma. FEBS Lett (1990) 1.06
A soluble binding protein specific for interleukin 1 beta is produced by activated mononuclear cells. Cytokine (1990) 1.06
Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol (2000) 1.06
In situ hybridisation. Ann Rheum Dis (1990) 1.04
Genetic association between an AACC insertion in the 3'UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis. J Invest Dermatol (2004) 1.03
Novel interleukin-1 receptor antagonist exon polymorphisms and their use in allele-specific mRNA assessment. Hum Genet (1996) 1.02
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet (1996) 1.02
Genetics of tumour necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm (1995) 1.02
Novel genetic association between the corneodesmosin (MHC S) gene and susceptibility to psoriasis. Hum Mol Genet (1999) 1.01
In situ hybridization of interleukin-1 in CD14-positive cells in rheumatoid arthritis. Clin Immunol Immunopathol (1992) 1.01
Human decidua: a source of interleukin-1. Obstet Gynecol (1989) 1.00
Infection and labor: the detection of endotoxin in amniotic fluid. Am J Obstet Gynecol (1987) 0.99
IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxford) (2000) 0.99
An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet (1998) 0.99
Interleukin 1 in rheumatoid arthritis: potentiation of immune responses within the joint. Lymphokine Res (1989) 0.98
IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort. Osteoarthritis Cartilage (2013) 0.98
Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab (1995) 0.97
Effect of interleukin-1 gene polymorphisms on gingival inflammation assessed by bleeding on probing in a periodontal maintenance population. J Periodontal Res (2000) 0.97
Interleukin 1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int (1990) 0.96
The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians (1983) 0.96
No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol (1993) 0.96
Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region. Hum Genet (2000) 0.95
A tumour necrosis factor alpha polymorphism is not associated with rheumatoid arthritis. Ann Rheum Dis (1995) 0.95
Failure to detect paramyxovirus sequences in Paget's disease of bone using the polymerase chain reaction. J Bone Miner Res (1991) 0.94
Genetic polymorphism of human interleukin-1 alpha. Eur J Immunol (1993) 0.94
Interleukin-1 in myocardium and coronary arteries of patients with dilated cardiomyopathy. J Mol Cell Cardiol (1998) 0.92
Combined sib-TDT and TDT provide evidence for linkage of the interleukin-1 gene cluster to erosive rheumatoid arthritis. Hum Mol Genet (1999) 0.91
Analysis of the association between diabetic nephropathy and polymorphisms in the aldose reductase gene in Type 1 and Type 2 diabetes mellitus. Diabet Med (2001) 0.91
Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J Periodontal Res (1999) 0.91
A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol (2001) 0.88
An intronic polymorphic repeat sequence modulates interleukin-1 alpha gene regulation. Mol Immunol (1996) 0.88
Association of the interleukin 1 receptor antagonist gene with ulcerative colitis in Northern European Caucasians. Gut (2001) 0.88
Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement. Acta Derm Venereol (1990) 0.87
Kinetics of IL1 beta mRNA and protein accumulation in human mononuclear cells. Immunol Lett (1991) 0.87
Autoregulation of interleukin 1 production. Eur J Immunol (1989) 0.87
The effect of febrile temperatures on biologic actions of interferons: abrogation of suppression of delayed-type hypersensitivity and antibody production. J Immunol (1984) 0.87
Genetic analysis of the interleukin-1 receptor antagonist and its homologue IL-1L1 in alopecia areata: strong severity association and possible gene interaction. Eur J Immunogenet (2002) 0.86
Polymorphic tandem repeat region in interleukin-1 alpha intron 6. Hum Genet (1993) 0.86
Absence of correlations between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatol Int (1990) 0.86
Absence of lentiviral and human T cell leukemia viral sequences in patients with rheumatoid arthritis. Arthritis Rheum (1994) 0.86
Psoriasis and interleukin-1. A translation. J R Coll Physicians Lond (1993) 0.86
An allele of the interleukin-1 receptor antagonist as a genetic severity factor in alopecia areata. J Invest Dermatol (1995) 0.85
TNF2, a polymorphism of the tumour necrosis-alpha gene promoter, is a component of the celiac disease major histocompatibility complex haplotype. Eur J Immunol (1996) 0.85
Personalized medicine: will dentistry ride the wave or watch from the beach? J Dent Res (2012) 0.85
Comparative analysis of the genetic associations of HLA-DR3 and tumour necrosis factor alpha with human IDDM. Diabetologia (1994) 0.84
Candidate genes as potential links between periodontal and cardiovascular diseases. Ann Periodontol (2001) 0.84
A negative regulatory region containing a glucocorticosteroid response element (nGRE) in the human interleukin-1beta gene. DNA Cell Biol (1997) 0.84
Plasma levels of interleukin-1-alpha in rheumatoid arthritis. Br J Rheumatol (1991) 0.84
Functional correlates of the interleukin-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun (2004) 0.83
Interleukin 1 activity produced by human rheumatoid and normal dendritic cells. Scand J Immunol (1986) 0.82
Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis. Genes Immun (2005) 0.82
The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and IPAA in ulcerative colitis. Gastroenterology (2001) 0.82